# Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib clinical trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/neoadjuvant-toripalimab-combined-with-gemcitabine-and-cisplatin-in-resectable/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Xiaotao Huang,Qiaodan Liu,Guihua Zhong,Yingpeng Peng,Ye Liu,Lizhong Liang,Haiyu Hong,Weineng Feng,Shuang Yang,Yaqin Zhang,Shiping Xian,Zhanyu Li,Yuling Zhou,Zhaoyuan Zhang,Wen Jiang,Jun Liang,Zhigang Liu |
| Citations | 74 |
| DOI | 10.1186/s13046-022-02510-2 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://jeccr.biomedcentral.com/counter/pdf/10.1186/s13046-022-02510-2 |
| OpenAlex ID | https://openalex.org/W4304694229 |
| PMID | 36224603 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Weineng Feng](https://scholariq.org/researchers/weineng-feng/)

## Paper journal

- [Journal of Experimental & Clinical Cancer Research](https://scholariq.org/journals/journal-of-experimental-and-clinical-cancer-research/)

## Paper primary topic

- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)

## Paper topics

- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.